Deciphera Pharmaceuticals Company

At Deciphera remains steadfast in mission to improve the lives of people living with cancer - and that passion for making a difference extends to the patient groups and communities in which people live and work.

Estimated Revenue: $10M to $50M
Funding Status: IPO
Headquarters: United States
Founded Date: 2003
Technology: Small Molecules
Industry: Genomic and Epigenominc Instabillity
Employee Number: 101-250